ARCHIVES

Age-adjusted cancer incidence and mortality down slightly, annual report finds.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

ASCO President Swain: “Shattering Impact on Cancer Enterprise”

February 15, 2013

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

July 3, 2009

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

April 22, 1983

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

October 26, 1984

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011